In the planet where health and affordability collide, It can be putting how Novo Nordisk's copyright has become a lifeline For a lot of. Although the manufacturing costs seem affordable, the retail price ranges generally leave you questioning the fairness of accessibility.California biotech behemoth Amgen ditched options for an experimental weight